Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.50
-0.49-6.13%
At close: -
$7.84
0.344.53%
After Hours: 6:22 PM EDT
Comments
Loading...
Seres Therapeutics (MCRB) Forecast
NewsEarningsSeres Therapeutics (MCRB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Seres Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MCRB | Benzinga
Explore Seres Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MCRB.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Seres Therapeutics (MCRB) stock?
You can purchase shares of Seres Therapeutics (NASDAQ:MCRB) through any online brokerage.
Who are Seres Therapeutics (MCRB) competitors?
Other companies in Seres Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Skye Bioscience (NASDAQ:SKYE), OncoCyte (NASDAQ:OCX) and Immuneering (NASDAQ:IMRX).
What is the forecast, or price target, for Seres Therapeutics (MCRB) stock?
Seres Therapeutics has a consensus price target of $10.46.
What is the current price for Seres Therapeutics (MCRB)?
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $7.84 last updated June 13, 2025 at 6:22 PM EDT.
Does Seres Therapeutics (MCRB) pay a dividend?
There are no upcoming dividends for Seres Therapeutics.
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Seres Therapeutics (MCRB) going to split?
There is no upcoming split for Seres Therapeutics.
What sector and industry does Seres Therapeutics (MCRB) operate in?
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
